Leicestershire Health Community
Medicines Formulary
 
back
3 Respiratory system
03-11 Antifibrotics

Pirfenidone
Restricted

For treatment of idiopathic pulmonary fibrosis in line with NICE TA 504 only.
For use by specialist respiratory physicians only
High Cost Therapy excluded to tariff commissioned by NHSE
Blueteq prior approval required before initiation

Date of entry of decision to Formulary: July 2013 (Updated April 2018)


November 14: Not supported by TAS for patients with FVC 80-90%

Link  Leicestershire Evaluation: Pirfenidone FVC 80% in Pulmonary Fibrosis
Link  NICE TA 504: Pirfenidone for treating Idiopathic Pulmonary Fibrosis (REPLACES NICE TA 282)
 

Restricted Drug Red View adult BNF  View SPC online  HCD
Nintedanib
Restricted

In line with NICE TA 379 only by specialist Respiratory Consultants.

Date of entry of decision to Formulary: April 2016

Link  Leicestershire Evaluation: Nintedanib in Pulmonary Fibrosis
Link  NICE TA 379: Nintedanib for treating idiopathic pulmonary fibrosis
 

Restricted Drug Red View adult BNF  View SPC online  HCD